BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33483736)

  • 21. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
    Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in the growth factor signal transduction pathways and modulators of the cell cycle in endocervical cells from macaques exposed to TCDD.
    Enan E; El-Sabeawy F; Scott M; Overstreet J; Lasley B
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):283-93. PubMed ID: 9707505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors.
    Dou X; Huang H; Jiang L; Zhu G; Jin H; Jiao N; Zhang L; Liu Z; Zhang L
    Eur J Med Chem; 2020 Sep; 201():112445. PubMed ID: 32603981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-Pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor.
    Kammerer B; Scheible H; Albrecht W; Gleiter CH; Laufer S
    Drug Metab Dispos; 2007 Jun; 35(6):875-83. PubMed ID: 17344341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatment.
    Kato R; Obara W; Matsuura T; Kato Y; Iwasaki K; Fujioka T
    Jpn J Clin Oncol; 2014 May; 44(5):479-85. PubMed ID: 24688083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single nucleotide polymorphisms (SNPs) are highly conserved in rhesus (Macaca mulatta) and cynomolgus (Macaca fascicularis) macaques.
    Street SL; Kyes RC; Grant R; Ferguson B
    BMC Genomics; 2007 Dec; 8():480. PubMed ID: 18166133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Jun N-terminal kinase-3 (JNK3)/stress-activated protein kinase-beta (SAPKbeta) binds and phosphorylates the neuronal microtubule regulator SCG10.
    Neidhart S; Antonsson B; Gilliéron C; Vilbois F; Grenningloh G; Arkinstall S
    FEBS Lett; 2001 Nov; 508(2):259-64. PubMed ID: 11718727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS No. 7487-94-7) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Feb; 408():1-260. PubMed ID: 12621522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of 1-Pyrimidinyl-2-Aryl-4,6-Dihydropyrrolo [3,4-d]Imidazole-5(1
    Jang M; Oh Y; Cho H; Yang S; Moon H; Im D; Hah JM
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32131443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects.
    Kim MH; Lee J; Jung K; Kim M; Park YJ; Ahn H; Kwon YH; Hah JM
    Bioorg Med Chem; 2013 Apr; 21(8):2271-2285. PubMed ID: 23498914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.
    Vanderkerken K; Medicherla S; Coulton L; De Raeve H; Willems A; Lawson M; Van Camp B; Protter AA; Higgins LS; Menu E; Croucher PI
    Cancer Res; 2007 May; 67(10):4572-7. PubMed ID: 17495322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
    Fang Y; Chen Y; Yu L; Zheng C; Qi Y; Li Z; Yang Z; Zhang Y; Shi T; Luo J; Liu M
    J Natl Cancer Inst; 2013 Jan; 105(1):47-58. PubMed ID: 23178439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanism mediating cytotoxic activity of axitinib in sunitinib-resistant human renal cell carcinoma cells.
    Miyazaki A; Miyake H; Fujisawa M
    Clin Transl Oncol; 2016 Sep; 18(9):893-900. PubMed ID: 26597115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role and clinical significance of TGF‑β1 and TGF‑βR1 in malignant tumors (Review).
    Wang J; Xiang H; Lu Y; Wu T
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33604683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute lymphoid and gastrointestinal toxicity induced by selective p38alpha map kinase and map kinase-activated protein kinase-2 (MK2) inhibitors in the dog.
    Morris DL; O'Neil SP; Devraj RV; Portanova JP; Gilles RW; Gross CJ; Curtiss SW; Komocsar WJ; Garner DS; Happa FA; Kraus LJ; Nikula KJ; Monahan JB; Selness SR; Galluppi GR; Shevlin KM; Kramer JA; Walker JK; Messing DM; Anderson DR; Mourey RJ; Whiteley LO; Daniels JS; Yang JZ; Rowlands PC; Alden CL; Davis JW; Sagartz JE
    Toxicol Pathol; 2010 Jun; 38(4):606-18. PubMed ID: 20448081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 May; 358():1-142. PubMed ID: 12695783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports.
    Négrier S; Moriceau G; Attignon V; Haddad V; Pissaloux D; Guerin N; Carrie C
    J Med Case Rep; 2018 Nov; 12(1):351. PubMed ID: 30474572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold.
    Graczyk PP; Khan A; Bhatia GS; Palmer V; Medland D; Numata H; Oinuma H; Catchick J; Dunne A; Ellis M; Smales C; Whitfield J; Neame SJ; Shah B; Wilton D; Morgan L; Patel T; Chung R; Desmond H; Staddon JM; Sato N; Inoue A
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4666-70. PubMed ID: 16153829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of JNK3: a kinase implicated in neuronal apoptosis.
    Xie X; Gu Y; Fox T; Coll JT; Fleming MA; Markland W; Caron PR; Wilson KP; Su MS
    Structure; 1998 Aug; 6(8):983-91. PubMed ID: 9739089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.